What is Molbio Diagnostics Ltd. Quarterly Revenue?

Molbio Diagnostics Ltd. Quarterly Revenue Molbio Diagnostics Jun-2026 Quarterly Revenue is Rs 401 Cr which is growth of 314.0% YoY.

What is Molbio Diagnostics Ltd. Quarterly Net Profit?

Molbio Diagnostics Ltd. Quarterly Net Profit Molbio Diagnostics Jun-2026 Quarterly Net Profit is Rs 57 Cr which is growth of 522.4% YoY.

What is Molbio Diagnostics Ltd. Annual Revenue?

Molbio Diagnostics Ltd. Annual Revenue Molbio Diagnostics Mar-2026 Annual Revenue is Rs 1,321 Cr which is growth of 35.1% YoY.

What is Molbio Diagnostics Ltd. Annual Net Profit?

Molbio Diagnostics Ltd. Annual Net Profit Molbio Diagnostics Mar-2026 Annual Net Profit is Rs 145 Cr which is growth of 3.4% YoY.

What is Molbio Diagnostics Ltd. Total Shareholders Fund?

Molbio Diagnostics Ltd. Total Shareholders Fund Molbio Diagnostics Mar-2026 Total Shareholders Fund is Rs 1,135 Cr which is growth of 14.6% YoY.

What is Molbio Diagnostics Ltd. Total Assets?

Molbio Diagnostics Ltd. Total Assets Molbio Diagnostics Mar-2026 Total Assets is Rs 1,741 Cr which is growth of 33.1% YoY.

What is Molbio Diagnostics Ltd. Book Value Per Share?

Molbio Diagnostics Ltd. Book Value Per Share Molbio Diagnostics Mar-2026 Book Value Per Share is 101 Rs which is growth of -77.1% YoY.

What is Molbio Diagnostics Ltd. ROE?

Molbio Diagnostics Ltd. ROE Molbio Diagnostics Mar-2026 ROE is 13% which is growth of 1.4% YoY.

What is Molbio Diagnostics Ltd. Cash From Operating Activity?

Molbio Diagnostics Ltd. Cash From Operating Activity Molbio Diagnostics Mar-2026 Cash From Operating Activity is Rs -38 Cr which is growth of -115.3% YoY.

What is Molbio Diagnostics Ltd. Net Cash Flow?

Molbio Diagnostics Ltd. Net Cash Flow Molbio Diagnostics Mar-2026 Net Cash Flow is Rs -2 Cr which is growth of -101.4% YoY.

Molbio Diagnostics Ltd.

NSE: MOLBIO | BSE: 544866

Download real time

Tests Performed

36.70(2.79%)

655.6K

NSE+BSE Volume

NSE 03 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting

The next board meeting for Molbio Diagnostics is on 05 Nov 2026 for the purpose of Quarterly Results See details

Molbio Diagnostics quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Molbio Diagnostics quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Molbio Diagnostics Jun-2026 Quarterly Revenue is Rs 401 Cr which is growth of 314.0% YoY.
POSITIVE
Quarterly Net Profit Molbio Diagnostics Jun-2026 Quarterly Net Profit is Rs 57 Cr which is growth of 522.4% YoY.

Molbio Diagnostics Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Jun '25
TOTAL_SR_Q Total Rev. ⌄	400.8	441.5	96.8
SR_Q Operating Rev.	399.4	438.7	95.3
OI_Q Other Income	1.4	2.7	1.5
OEXPNS_Q Operating Exp.	307.7	331.7	105
OEXPNS_Q Operating Exp.	307.7	331.7	105
OP_Q Operating Profit	91.6	107	-9.6
OPMPCT_Q Operating Profit Margin %	22.94%	24.40%	-10.11%
DEP_Q Depr.	8.4	9.9	7.4
INT_Q Interest	8.7	9.3	1.9
PBT_Q Profit Before Tax	75.9	90.7	-17.5
TAX_Q Tax	19.3	25	-4.1
NP_Q Net Profit	56.6	65.7	-13.4
EPS_adj_Q EPS Adj. latest	4.9	5.7	-1.2
NP_TTM Net profit TTM	-	-	-
EPS_TTM Basic EPS TTM	-	-	-
earnings_transcripts Earnings Transcripts
results_pdf Results PDF
result_notes Result Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Molbio Diagnostics competitor comparison and performance snapshot within industry

Molbio Diagnostics annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Molbio Diagnostics Mar-2026 Annual Revenue is Rs 1,321 Cr which is growth of 35.1% YoY.
POSITIVE
Annual Net Profit Molbio Diagnostics Mar-2026 Annual Net Profit is Rs 145 Cr which is growth of 3.4% YoY.

Molbio Diagnostics Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
SR_A Total Rev. Ann. ⌄	58%	1,321.1	977.6	762.8	334.7	781.3
TotalOperatingRevenues_A Operating Rev. Ann.	59%	1,313.4	971.2	756.3	326.6	776.2
OI_A Other Income Ann.	-1.7%	7.7	6.4	6.5	8.1	5.1
OEXPNS_A Operating Exp. Ann.	54.7%	1,061.5	745.6	552.6	286.5	457
OEXPNS_A Operating Exp. Ann.	54.7%	1,061.5	745.6	552.6	286.5	457
OP_A Operating Profit Ann.	84.5%	251.9	225.6	203.7	40.1	319.3
OPMPCT_A OPM Ann. %	16.7%	19.06%	23.08%	26.70%	11.98%	40.86%
TotalExpenses_A Total Exp. Ann. ⌄	53.2%	1,120.4	780.8	583.8	311.8	523.6
OtherExpenses_A Other Exp. Ann.	59.4%	474.8	300.4	242.4	117.3	159.3
EmployeeBenefitExpenses_A Employee Exp. Ann.	33.7%	81.2	65.7	38.6	34	28.8
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-
CostOfFuel_A Cost Of Fuel Ann.	-
EBIDT_A EBITDA Ann.	75.3%	259.6	232	210.2	48.2	324.4
EBIDTPCT_A EBITDA Ann. margin %	10.9%	19.65%	23.73%	27.56%	14.40%	41.52%
INT_A Interest Ann.	57.8%	23.2	8.9	7.6	5.9	24.9
DEP_A Depr.	22.5%	35.7	26.3	23.6	19.4	41.8
PBT_A PBT Ann.	105.1%	197.6	188	151.9	22.9	257.8
TAX_A Tax Ann.	93.5%	52.9	48.2	40.8	7.3	70.6
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	110.1%	144.6	139.8	111.1	15.6	187.2
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-
NP_A Net Profit Ann.	110.1%	144.6	139.8	111.1	15.6	187.2
NETPCT_A NPM Ann. %	32.2%	11.01%	14.39%	14.69%	4.76%	24.11%
EPS_adj_A EPS Adj. latest Ann.	108%	12.6	12.1	9.6	1.4	16.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

35.1%

2Y CAGR

31.6%

3Y CAGR

58%

Net Profit Ann.

1Y CHG

3.4%

2Y CAGR

14.1%

3Y CAGR

110.1%

Operating Exp. Ann.

1Y CHG

42.4%

2Y CAGR

38.6%

3Y CAGR

54.7%

Molbio Diagnostics balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Molbio Diagnostics Mar-2026 Total Shareholders Fund is Rs 1,135 Cr which is growth of 14.6% YoY.
POSITIVE
Total Assets Molbio Diagnostics Mar-2026 Total Assets is Rs 1,741 Cr which is growth of 33.1% YoY.

Molbio Diagnostics Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	15.4%	1,134.7	990.1	850	739	683.3
EQCAP_A Equity Share Capital Ann.	70%	11.3	2.3	2.3	2.3	2.3
TotalShareCapital_A Total Share Capital Ann.	70%	11.3	2.3	2.3	2.3	2.3
ReservesAndSurplus_A Reserves Plus Surplus Ann.	15.1%	1,123.4	987.8	847.4	736.4	680.7
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	15.1%	1,123.4	987.8	847.4	736.4	680.7
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	316.8%	224.4	13.5	17.4	3.1	4
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	85%	13.3	7.3	2.3	2.1	2.7
CL_A Total Current Liabilities Ann. ⌄	29.1%	381.5	303.9	209.8	177.5	186.9
TradePayables_A Trade Payables Ann.	34%	179.6	235.5	95.9	74.6	47.4
OtherCurrentLiabilities_A Other Current Liabilities Ann.	13.2%	59	42.3	46.8	40.7	31.1
ShortTermProvisions_A ST Provisions Ann.	28.2%	19.4	14.9	15.8	9.2	4.3
TL_A Total Capital Plus Liabilities Ann.	23.7%	1,740.6	1,307.5	1,077.2	919.5	874.2
FixedAssets_A Fixed Assets Ann. ⌄	11.6%	263	232.5	210.5	189.3	195
TangibleAssets_A Tangible Assets Ann.	11.2%	257.1	213.8	174	187	194.8
IntangibleAssets_A Intangible Assets Ann.	-50%	0.3	1.2	1.9	2.4	0.3
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	5.6	17.6	1.6
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	33.6%	737.1	480.9	353.7	308.8	242.5
NonCurrentInvestments_A Non Current Investments Ann.	80.7%	317.4	95.4	53.8	53.8	8.7
DeferredTaxAssets_A Deferred Tax Assets Ann.	98.2%	48.3	41.2	23.2	6.2	6.6
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	14	27.2	5
OtherNonCurrentAssets_A Other Non Current Assets Ann.	16.6%	94.4	84.6	61.2	59.5	32.2
CA_A Total Current Assets Ann. ⌄	18%	1,003.5	826.5	723.5	610.8	631.7
CurrentInvestments_A Current Investments Ann.	-
TradeReceivables_A Trade Receivables Ann.	27.4%	358.6	227.7	360.3	173.3	240.6
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	187.3%	109.1	110.8	18.3	4.6	6.4
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-58.2%	0.9			12.3	20
OtherCurrentAssets_A Other Current Assets Ann.	14.2%	138.2	77.8	52.4	92.9	68.9
TA_A Total Assets Ann.	23.7%	1,740.6	1,307.5	1,077.2	919.5	874.2
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	94.8%	243.2	180.7	119.7	32.9	35.9
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	9
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	80.7%	317.4	95.4	53.8	53.8	8.7
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

33.1%

2Y CAGR

27.1%

3Y CAGR

23.7%

Total Current Liabilities Ann.

1Y CHG

25.5%

2Y CAGR

34.8%

3Y CAGR

29.1%

Total ShareHolders Funds Ann.

1Y CHG

14.6%

2Y CAGR

15.5%

3Y CAGR

15.4%

Molbio Diagnostics ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Molbio Diagnostics Mar-2026 Book Value Per Share is 101 Rs which is growth of -77.1% YoY.
POSITIVE
ROE Molbio Diagnostics Mar-2026 ROE is 13% which is growth of 1.4% YoY.

Molbio Diagnostics Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
BVSH_A BVSH Ann.	-68.7%	100.6	438.9	3,771	3,278.5	3,042.2
ROA_A RoA Ann. %	70%	8.30%	10.69%	10.31%	1.69%	21.41%
ROE_A ROE Ann. %	82.4%	12.74%	14.12%	13.07%	2.10%	27.39%
ROCE_A ROCE Ann. %	61.9%	16.46%	20.49%	21.51%	3.88%	41.12%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	10.2%	19.76%	23.88%	27.79%	14.75%	41.78%
PBITMargin_A EBIT Ann. Margin %	24.6%	17.04%	21.17%	24.67%	8.81%	36.41%
PBTMargin_A PBT Ann. Margin %	29.1%	15.04%	19.36%	20.08%	6.99%	33.20%
NETPCT_A NPM Ann. %	32.2%	11.01%	14.39%	14.69%	4.76%	24.11%
ASETTO_A Asset Turnover Ann. %	31%	0.9	0.8	0.8	0.4	-
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-8.6%	2.6	2.7	3.5	3.4	3.4
QuickRatio_A Quick Ratio Ann.	0%	1.6	1.4	2.1	1.6	1.8
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
CashEarningRetention_A Cash Earning Retention Ann. %	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	-
EVPerNetSales_A EV Per Net Sales Ann.	-	-	-	-	-	-
PBV_A Price To Book Value Adjusted	0%	15.58	15.58	15.58	15.58	15.58
EVPerEBITDA_A EV Per EBITDA Ann.	-	-	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	-	-	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-
EYield_A Earnings Yield Ann.	-
DEBT_CE_A Total Debt to Total Equity Ann.	44.2%	0.3	0	0.1	0.1	0.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-9.8%

2Y CAGR

-1.3%

3Y CAGR

82.4%

RoA Ann. %

1Y CHG

-22.4%

2Y CAGR

-10.3%

3Y CAGR

70%

Current Ratio Ann.

1Y CHG

-3.7%

2Y CAGR

-13.8%

3Y CAGR

-8.6%

Molbio Diagnostics cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Molbio Diagnostics Mar-2026 Cash From Operating Activity is Rs -38 Cr which is growth of -115.3% YoY.
NEGATIVE
Net Cash Flow Molbio Diagnostics Mar-2026 Net Cash Flow is Rs -2 Cr which is growth of -101.4% YoY.

Molbio Diagnostics Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
CFO_A Cash from Operating Act. Ann. ⌄	-	-38	248.6	37.7	67.9	97.8
PBT_A PBT Ann.	105.1%	197.6	188	151.9	22.9	257.8
INT_A Interest Ann.	57.8%	23.2	8.9	7.6	5.9	24.9
TAX_A Tax Ann.	93.5%	52.9	48.2	40.8	7.3	70.6
CFI_A Cash from Investing Act. Ann.	-	-256.3	-97.9	-31.4	-51	-86.7
CFA_A Cash from Financing Act. Ann.	-	292.4	-17.4	-24.2	-18.6	-20
NCF_A Net Cash Flow Ann. ⌄	-	-1.8	133.3	-17.9	-1.7	-8.9
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	164.3%	110.8	-22.6	-4.7	6	15
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	193.7%	108.9	110.8	-22.6	4.3	6

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Molbio Diagnostics investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Molbio Diagnostics quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents